Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-16 Sale | 2023-05-18 8:30 pm | Replimune Group Inc. | REPL | Astley-Sparke Philip Chief Executive Officer | 17,902 | $18.05 | $323,131 | 1,525,278 (Direct) | View |
| 2022-05-16 Sale | 2022-05-18 7:00 pm | Replimune Group Inc. | REPL | Astley-Sparke Philip Chief Executive Officer | 9,632 | $14.59 | $140,531 | 1,401,080 (Direct) | View |
| 2021-03-02 Sale | 2021-03-04 2:26 pm | uniQure N.V. | QURE | Astley-Sparke Philip Director | 504 | $37.6 | $18,950 | 9,946 (Direct) | View |
| 2021-01-14 Sale | 2021-01-19 9:53 pm | Replimune Group Inc. | REPL | Astley-Sparke Philip Chief Executive Officer | 50,000 | $43.76 | $2,187,790 | 1,255,297 (Direct) | View |
| 2020-12-09 Sale | 2020-12-11 9:00 pm | Replimune Group Inc. | REPL | Astley-Sparke Philip Chief Executive Officer | 50,000 | $43.4 | $2,169,874 | 1,305,297 (Direct) | View |
| 2020-01-30 Sale | 2020-01-30 9:39 pm | uniQure N.V. | QURE | Astley-Sparke Philip Director | 807 | $59.23 | $47,799 | 6,005 (Direct) | View |
| 2019-11-06 Sale | 2019-11-08 9:16 pm | Replimune Group Inc. | REPL | Astley-Sparke Philip Executive Chairman | 29,000 | $17.01 | $493,290 | 1,355,297 (Direct) | View |
| 2019-11-04 Sale | 2019-11-06 7:38 pm | Replimune Group Inc. | REPL | Astley-Sparke Philip Executive Chairman | 29,000 | $17.03 | $493,754 | 1,384,297 (Direct) | View |
| 2019-10-31 Sale | 2019-11-04 4:16 pm | Replimune Group Inc. | REPL | Astley-Sparke Philip Executive Chairman | 14,500 | $17 | $246,500 | 1,413,297 (Direct) | View |
| 2019-09-23 Sale | 2019-09-25 4:31 pm | Replimune Group Inc. | REPL | Astley-Sparke Philip Executive Chairman | 14,500 | $17.05 | $247,225 | 1,427,797 (Direct) | View |
| 2019-08-01 Sale | 2019-08-05 12:21 pm | uniQure N.V. | QURE | Astley-Sparke Philip Director | 6,460 | $60.12 | $388,344 | 6,812 (Direct) | View |
| 2019-06-03 Sale | 2019-06-04 2:07 pm | uniQure N.V. | QURE | Astley-Sparke Philip Director | 6,000 | $63.63 | $381,779 | 13,272 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-04-01 Option Award | 2023-04-04 8:00 pm | N/A 2033-04-01 | Replimune Group Inc. | REPL | Astley-Sparke Philip Chief Executive Officer | 355,250 | $0 | 1,756,330 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 4:18 pm | N/A 2032-04-01 | Replimune Group Inc. | REPL | Astley-Sparke Philip Chief Executive Officer | 175,000 | $0 | 1,515,712 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-05 8:17 pm | N/A 2031-04-01 | Replimune Group Inc. | REPL | Astley-Sparke Philip Chief Executive Officer | 213,540 | $0 | 1,468,837 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 4:26 pm | N/A 2031-02-25 | uniQure N.V. | QURE | Astley-Sparke Philip Director | 6,489 | $0 | 14,557 (Direct) | View |
| 2020-04-01 Option Award | 2020-04-02 4:30 pm | N/A 2030-04-01 | Replimune Group Inc. | REPL | Astley-Sparke Philip Chief Executive Officer | 265,000 | $0 | 265,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 3:43 pm | N/A 2030-02-27 | uniQure N.V. | QURE | Astley-Sparke Philip Director | 5,683 | $0 | 11,688 (Direct) | View |